Last reviewed · How we verify
NCT05343247
Dental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta
trial testing Cameriere method in Amelogenesis Imperfecta in 416 participants. Completed in 23 April 2024.
15 April 2024
Quick facts
| Lead sponsor | Istanbul University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 416 |
| Start date | 1 March 2022 |
| Primary completion | 15 April 2024 |
| Estimated completion | 23 April 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Cameriere method
- London Atlas method
Conditions studied
- Amelogenesis Imperfecta — all drugs for Amelogenesis Imperfecta →
- Dental Age Estimation — all drugs for Dental Age Estimation →
Sponsor
Istanbul University
Who can join
Adults 5 to 13, any sex, with Amelogenesis Imperfecta or Dental Age Estimation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate whether there is a significant difference in dental age between children with amelogenesis imperfecta (AI) and healthy controls using Cameriere European formula and London Atlas. If there is a significant difference in dental age between children with AI and healthy controls, it is aimed to create a new formula.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05343247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amelogenesis Imperfecta
Currently open trials in the same condition.
- NCT07250906 — Oral Health Related Quality of Life of Children With Amelogenesis Imperfecta · recruiting
- NCT04704089 — Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects · recruiting
Other Istanbul University trials
Trials by the same sponsor.
- NCT07472946 — Whole-Body Vibration Exercise in Patients With Parkinson's Disease · NA · not yet recruiting
- NCT07433894 — Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis · not yet recruiting
- NCT07420049 — Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study · not yet recruiting
- NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
- NCT07473024 — pEEG-Guided Anesthesia and Behavioral Outcomes in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05343247 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul University
- Last refreshed: 22 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05343247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing